Latest


Lupin gets USFDA approval for oral contraceptive

  •   Fri, Sep 27 2013 08:09:03 PM

New Delhi, Sep 27 (IANS): Pharma major Lupin has received the US health regulator's approval to market a generic version of Warner Chilcott Company's 'Ovcon 35' tablets, an oral contraceptive, in the American market, the company said Friday.

The Mumbai-based company has received final approval for its VyfemlaTM Tablets (Norethindrone and Ethinyl Estradiol Tablets USP, 0.4mg/0.035 mg) from the US Food and Drugs Administration (USFDA).

"Lupin's US subsidiary Lupin Pharmaceuticals Inc (LPI) shall commence marketing the product shortly," Lupin said in a statement.

The oral contraceptive (OC) market in the US is valued at around $5 billion and is growing at around 8 percent annually.

According to IMS MAT March sales data, Warner Chilcott Company's Ovcon 35 tablets had annual US sales of around $22.3 million.

Lupin entered the OC space in the US market in September 2011 and currently has one of the largest OC pipeline for the US market, with 34 filings and 14 approvals so far.
  

Top Stories


Leave a Comment

Title: Lupin gets USFDA approval for oral contraceptive



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.

You might also like